Growth Metrics

Sarepta Therapeutics (SRPT) Profit After Tax Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 33.04%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 30.60%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -154.28%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.80%
7 Evaxion A 62.56 Bn 62.54 Bn - 16.53%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 47.10%
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn 38.22%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 38.22%
Dec 31, 2025 -55.68%
Sep 30, 2025 41.89%
Jun 30, 2025 41.79%
Mar 31, 2025 -62.12%
Dec 31, 2024 48.94%
Sep 30, 2024 39.22%
Jun 30, 2024 27.64%
Mar 31, 2024 30.37%
Dec 31, 2023 30.87%
Sep 30, 2023 40.72%
Jun 30, 2023 45.86%
Mar 31, 2023 -209.14%
Dec 31, 2022 22.61%
Sep 30, 2022 -26.83%
Jun 30, 2022 5.74%
Mar 31, 2022 -11.07%
Dec 31, 2021 4.69%
Sep 30, 2021 14.26%
Jun 30, 2021 9.35%
Mar 31, 2021 -67.86%
Dec 31, 2020 -99.07%
Sep 30, 2020 -60.27%
Jun 30, 2020 -33.74%
Mar 31, 2020 -30.22%
Dec 31, 2019 -38.64%
Sep 30, 2019 -30.58%
Jun 30, 2019 -64.32%
Mar 31, 2019 -8.64%
Dec 31, 2018 -29.63%
Sep 30, 2018 -13.72%
Jun 30, 2018 -37.70%
Mar 31, 2018 16.87%
Dec 31, 2017 18.55%
Sep 30, 2017 -17.77%
Jun 30, 2017 -23.01%
Mar 31, 2017 70.70%
Dec 31, 2016 -115.65%
Sep 30, 2016 -10.52%
Jun 30, 2016 -48.43%
Mar 31, 2016 -12.41%
Dec 31, 2015 -1.38%
Sep 30, 2015 -1.58%
Jun 30, 2015 -93.16%
Mar 31, 2015 -51.50%
Dec 31, 2014 -215.82%
Sep 30, 2014 -93.72%
Jun 30, 2014 -205.40%
Mar 31, 2014 -159.25%
Dec 31, 2013 -74.81%
Sep 30, 2013 -124.49%
Jun 30, 2013 -35.75%